Minerva Surgical Stock Net Income
| UTRS Stock | USD 0.0001 0.00 0.00% |
As of the 13th of February 2026, Minerva Surgical secures the Risk Adjusted Performance of (0.04), mean deviation of 5.34, and Standard Deviation of 18.1. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Minerva Surgical, as well as the relationship between them. Please verify Minerva Surgical market risk adjusted performance and treynor ratio to decide if Minerva Surgical is priced some-what accurately, providing market reflects its recent price of 1.0E-4 per share. As Minerva Surgical appears to be a penny stock we also strongly suggest to check its information ratio numbers.
Minerva Surgical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Minerva Surgical's valuation are provided below:Minerva Surgical does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Minerva |
Minerva Surgical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Minerva Surgical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Minerva Surgical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Minerva Surgical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Minerva Surgical or generate 0.0% return on investment in Minerva Surgical over 90 days. Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minima... More
Minerva Surgical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Minerva Surgical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Minerva Surgical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 150.0 |
Minerva Surgical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Minerva Surgical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Minerva Surgical's standard deviation. In reality, there are many statistical measures that can use Minerva Surgical historical prices to predict the future Minerva Surgical's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (1.32) | |||
| Total Risk Alpha | (2.80) | |||
| Treynor Ratio | (0.86) |
Minerva Surgical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.85) | |||
| Mean Deviation | 5.34 | |||
| Coefficient Of Variation | (1,494) | |||
| Standard Deviation | 18.1 | |||
| Variance | 327.74 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (1.32) | |||
| Total Risk Alpha | (2.80) | |||
| Treynor Ratio | (0.86) | |||
| Maximum Drawdown | 150.0 | |||
| Skewness | 0.8439 | |||
| Kurtosis | 21.17 |
Minerva Surgical Backtested Returns
Minerva Surgical has Sharpe Ratio of -0.0696, which conveys that the firm had a -0.0696 % return per unit of risk over the last 3 months. Minerva Surgical exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Minerva Surgical's Standard Deviation of 18.1, risk adjusted performance of (0.04), and Mean Deviation of 5.34 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.42, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Minerva Surgical will likely underperform. At this point, Minerva Surgical has a negative expected return of -1.31%. Please make sure to verify Minerva Surgical's treynor ratio and day typical price , to decide if Minerva Surgical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.49 |
Average predictability
Minerva Surgical has average predictability. Overlapping area represents the amount of predictability between Minerva Surgical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Minerva Surgical price movement. The serial correlation of 0.49 indicates that about 49.0% of current Minerva Surgical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Minerva Surgical reported net income of (34.11 Million). This is 110.0% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 105.97% higher than that of the company.
Minerva Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Minerva Surgical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Minerva Surgical could also be used in its relative valuation, which is a method of valuing Minerva Surgical by comparing valuation metrics of similar companies.Minerva Surgical is currently under evaluation in net income category among its peers.
Minerva Fundamentals
| Return On Equity | -1.6 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.51) % | |||
| Current Valuation | 42.81 M | |||
| Shares Outstanding | 8.88 M | |||
| Shares Owned By Insiders | 0.42 % | |||
| Shares Owned By Institutions | 89.86 % | |||
| Number Of Shares Shorted | 37.42 K | |||
| Price To Book | 0.51 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 50.29 M | |||
| Gross Profit | 27.24 M | |||
| EBITDA | (30.88 M) | |||
| Net Income | (34.11 M) | |||
| Cash And Equivalents | 22.39 M | |||
| Cash Per Share | 0.78 X | |||
| Total Debt | 39.69 M | |||
| Debt To Equity | 1.30 % | |||
| Current Ratio | 2.40 X | |||
| Book Value Per Share | 2.28 X | |||
| Cash Flow From Operations | (35.57 M) | |||
| Short Ratio | 0.51 X | |||
| Earnings Per Share | (7.61) X | |||
| Target Price | 3.0 | |||
| Number Of Employees | 174 | |||
| Beta | 0.83 | |||
| Market Capitalization | 13.14 M | |||
| Total Asset | 68.9 M | |||
| Retained Earnings | (283.67 M) | |||
| Working Capital | 21.84 M | |||
| Z Score | -5.93 | |||
| Net Asset | 68.9 M |
About Minerva Surgical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Pink Sheet Analysis
When running Minerva Surgical's price analysis, check to measure Minerva Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Surgical is operating at the current time. Most of Minerva Surgical's value examination focuses on studying past and present price action to predict the probability of Minerva Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Surgical's price. Additionally, you may evaluate how the addition of Minerva Surgical to your portfolios can decrease your overall portfolio volatility.